Development of anti-CXCL13 monoclonal antibody for the treatment of multiple sclerosis

被引：0

作者：

Klimatcheva, E. ^{[1
]}

Pandina, T. ^{[1
]}

Reilly, C. ^{[1
]}

Decker, J. ^{[1
]}

Jonason, A. ^{[1
]}

Scrivens, M. ^{[1
]}

Huang, H. ^{[1
]}

Cornelius, C. ^{[1
]}

Doherty, M. ^{[1
]}

Veeraraghavan, J. ^{[1
]}

Kirk, R. ^{[1
]}

Caplan, J. ^{[1
]}

Howell, A. ^{[1
]}

Kenney, P. ^{[1
]}

Seigel, G. ^{[1
]}

Torno, S. ^{[1
]}

Richards, T. ^{[1
]}

Fisher, T. ^{[1
]}

Evans, E. ^{[1
]}

Paris, M. ^{[1
]}

Leonard, J. ^{[1
]}

Watkins, R. ^{[1
]}

Foster, P. ^{[1
]}

Bowers, W. ^{[1
]}

Zauderer, M. ^{[1
]}

Smith, E. ^{[1
]}

机构：

[1] Vaccinex Inc, Rochester, MN USA

来源：

MULTIPLE SCLEROSIS JOURNAL | 2012年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：413 / 413

页数：1

共 50 条

[31] Monoclonal Antibodies in the Treatment of Multiple Sclerosis
Di Pauli, F.
Berger, T.
Reindl, M.
[J]. CURRENT MEDICINAL CHEMISTRY, 2009, 16 (36) : 4858 - 4868
[32] Monoclonal antibodies in treatment of multiple sclerosis
Rommer, P. S.
Dudesek, A.
Stueve, O.
Zettl, U. K.
[J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2014, 175 (03): : 373 - 384
[33] Monoclonal Antibodies for Multiple Sclerosis Treatment
Palavra, Filipe
[J]. ACTA MEDICA PORTUGUESA, 2015, 28 (05): : 640 - 651
[34] Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis
Wootla, Bharath
Watzlawik, Jens O.
Stavropoulos, Nikolaos
Wittenberg, Nathan J.
Dasari, Harika
Abdelrahim, Murtada A.
Henley, John R.
Oh, Sang-Hyun
Warrington, Arthur E.
Rodriguez, Moses
[J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (06) : 827 - 839
[35] Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review
Elsbernd, Paul M.
Carter, Jonathan L.
[J]. BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 255 - 263
[36] Anti lingo 1 (opicinumab) a new monoclonal antibody tested in relapsing remitting multiple sclerosis
Ruggieri, Serena
Tortorella, Carla
Gasperini, Claudio
[J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (11) : 1081 - 1089
[37] ELOTUZUMAB Anti-CS1 Monoclonal Antibody Treatment of Multiple Myeloma
Harvey, R. D.
Gleason, C.
Lewis, C.
Lonial, S.
[J]. DRUGS OF THE FUTURE, 2013, 38 (07) : 461 - 465
[38] DARATUMUMAB Anti-CD38 Monoclonal Antibody, Treatment of Multiple Myeloma
Richardson, P.
Lokhorst, H.
Palumbo, A.
Nahi, H.
Laubach, J.
Gimsing, P.
Lisby, S.
Cakana, A.
Brun, N. Constantin
Plesner, T.
[J]. DRUGS OF THE FUTURE, 2013, 38 (08) : 545 - 554
[39] Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
Coles, AJ
Paolillo, A
Molyneux, P
Wing, MG
Hale, G
Miller, D
Waldmann, H
Compston, DAS
[J]. ANNALS OF NEUROLOGY, 1998, 44 (03) : 464 - 464
[40] Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis
Coles, AJ
Wing, MG
Molyneux, P
Paolillo, A
Davie, CM
Hale, G
Miller, D
Waldmann, H
Compston, A
[J]. ANNALS OF NEUROLOGY, 1999, 46 (03) : 296 - 304

← 1 2 3 4 5 →